Industry Spotlights Improvements To EMA's Post-Authorization Processes
This article was originally published in SRA
Executive Summary
Last year's streamlining of post-authorization procedures at the European Medicines Agency has gone down well with both industry and agency employees, according to the results of a joint survey by the EMA and EU drugs industry association EFPIA.